Pseudothrombopénie non EDTA-dépendante: à propos d'un cas

Pseudothrombopénie non EDTA-dépendante: à propos d'un cas

La pseudothrombopénie est un phénomène rare de laboratoire, expliquée par une agglutination in vitro des plaquettes. L'examen au microscope du frottis du sang périphérique est un examen clé, pour confirmer le diagnostic et pour éviter toute décision clinique et thérapeutique inadaptée voir dang...

Full description

Bibliographic Details
Main Authors:	Hicham Titou, Youssef Jalal, Mohammed Boui
Format:	Article
Language:	English
Published:	The Pan African Medical Journal 2017-02-01
Series:	The Pan African Medical Journal
Subjects:	anticoagulant héparine plaquettes pseudothrombopénie
Online Access:	https://www.panafrican-med-journal.com/content/article/26/88/pdf/88.pdf

Similar Items

Thrombasthénie de Glanzmann: à propos de 11 cas
by: Jean-Louis Ntumba Mukendi, et al.
Published: (2015-08-01)

Multiterminal nonreciprocal routing in an optomechanical plaquette via synthetic magnetism
by: Zhi-Xiang Tang, et al.
Published: (2023-01-01)

A new interpretation of prince Lazar’s “tipar” from the Rudnik mountain
by: Radičević Dejan, et al.
Published: (2021-01-01)

Prélèvement de plaquettes pour la chirurgie cardiaque: première expérience d'aphérèse à l'Hôpital Général de Douala
by: William Ngatchou, et al.
Published: (2018-09-01)

La lucite polymorphe: à propos d’un cas
by: Jawad El-Azhari, et al.
Published: (2019-09-01)

Carcinome basocellulaire: à propos d'un cas historique
by: Mohamed El Amraoui, et al.
Published: (2018-05-01)

L’étude microtopographique et la visualisation 3D dans l’analyse de gravures préhistoriques – L’exemple des pierres gravées de La Marche
by: Nicolas Mélard
Published: (2012-04-01)

Sculptor Oscar Nemon’s Medal Works During his Brussels Period
by: Daniel Zec
Published: (2020-01-01)

Updates in Anticoagulation Therapy Monitoring
by: Hannah L. McRae, et al.
Published: (2021-03-01)

Pharmacological properties of hirudin and its derivatives : potential clinical advantages over heparin /
by: 422288 Monreal, Manuel, et al.

Bivalirudin for cardiac catheterization in a pediatric patient with religious objection to the use of porcine-derived heparin
by: A. Caskey, et al.
Published: (2021-08-01)

Cost reduction associated with heparin-induced thrombocytopenia panel ordering for enoxaparin versus heparin for prophylactic and therapeutic use: A retrospective analysis in a community hospital setting
by: Harry Menon, et al.
Published: (2018-10-01)

Hémangiome surrénalien: à propos d'un cas
by: Noureddine Njoumi, et al.
Published: (2017-10-01)

Therapeutic inefficacy of protocol driven intravenous unfractionated heparin infusion in the current era
by: Kayla Torppey, et al.
Published: (2023-10-01)

Métastases intramédulaires d'un adénocarcinome pulmonaire: à propos d'un cas
by: Hicham Naji-Amrani, et al.
Published: (2015-01-01)

Effects of the synthetic thrombin inhibitor argatroban on fibrin- or clot-incorporated thrombin : comparison with heparin and recombinant hirudin /
by: Berry, Christopher N.

Comparison of recombinant hirudin and heparin as an anticoagulant in a cardiopulmonary bypass model /
by: Walenga, J. M.

Studies on the anticoagulant, antimetastatic and heparin-binding properties of ghilanten-relared inhibitors /
by: Brankamp, R. G.

Comparing the Effects of Three Heparinization Methods of Hemodialysis Set on the Amount of Clot Formation during Hemodialysis
by: M Kazemi, et al.
Published: (2005-07-01)

Safety of low-dose anticoagulation in extracorporeal membrane oxygenation using the Permanent Life Support System: a retrospective observational study
by: Kyungsub Song, et al.
Published: (2023-07-01)

Deep Venous Thrombosis Prophylaxis Practices in Surgical Intensive Care Unit Patients: A Cross-sectional Study
by: Alisha Singh, et al.
Published: (2021-02-01)

Strategies to Overcome Heparins’ Low Oral Bioavailability
by: Ana Rita Neves, et al.
Published: (2016-06-01)

Le schwannome pénien: à propos d'un cas
by: Younes Essatara, et al.
Published: (2014-05-01)

Un volumineux ostéome orbitaire : à propos d'un cas
by: Kamal Loutfi Nuiakh, et al.
Published: (2014-05-01)

A Literature Review of Pathophysiology, Clinical Manifestations, Medications and Optimal Dosage, Outpatient, and Post-hospitalization Use of Anticoagulation in COVID-19 Patients
by: Dimitrios Velissaris, et al.
Published: (2023-04-01)

Effects of Protamine Reversal on Coagulation Parameters After High-Dose Heparin Administration in Percutaneous Hepatic Chemosaturation Intervention
by: Michael Metze, et al.
Published: (2025-02-01)

Multifaceted role of heparin in oncology: from anticoagulation to anticancer mechanisms and clinical implications
by: Niranjan Koirala, et al.
Published: (2025-02-01)

Paragangliome malin orbitaire, à propos d'un cas
by: Idriss Benatiya Andaloussi, et al.
Published: (2012-06-01)

Heparin in sepsis: current clinical findings and possible mechanisms
by: Sihan Yu, et al.
Published: (2024-12-01)

Anticoagulation strategies in COVID-19 infected patients receiving ECMO support
by: Diaz Dayne, et al.
Published: (2023-09-01)

Spontaneous Breast Haematoma after Heparin Anticoagulation
by: Imran Yaseen Gani, et al.
Published: (2020-06-01)

Anticoagulation in COVID-19: why, what, and when
by: Khaled M Taema
Published: (2021-01-01)

Effects of Clopidogrel and Low-Molecular-Weight Heparin on Viability of Random Skin Flaps in Rats
by: Fabio Antonio Vieira, et al.
Published: (2016-09-01)

Periprocedural heparin bridging in patients receiving oral anticoagulation: a systematic review and meta-analysis
by: Jing Wen Yong, et al.
Published: (2017-12-01)

Rational Design of Anticoagulant Drugs Using Oligosaccharide Chemistry
by: Ahmed El Hadri, et al.
Published: (2011-02-01)

Unusual drug response and hemodynamics, VA – ECMO. A case report
by: Fayaz Mohammed Khazi, et al.
Published: (2016-04-01)

Applied Nanotechnologies in Anticoagulant Therapy: From Anticoagulants to Coagulation Test Performance of Drug Delivery Systems
by: Yuri B. G. Patriota, et al.
Published: (2021-05-01)

The methods for removal of direct oral anticoagulants and heparins to improve the monitoring of hemostasis: a narrative literature review
by: Aleksandra Frackiewicz, et al.
Published: (2023-05-01)

Bioequivalence of a biosimilar enoxaparin (Cloti‐Xa™) and its innovator (Clexane®): A single‐dose, randomized, double‐blind, two‐period, two‐treatment, two‐sequence, crossover, balanced study in healthy human subjects
by: Sumit Saxena, et al.
Published: (2022-08-01)

Evaluation of EDTA induced pseudothrombocytopenia and the effect of alternative anticoagulants
by: A Shrestha, et al.
Published: (2014-09-01)